Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RiboMed Biotechnologies, Inc.
Phoenix, Arizona, United Statesventureradar.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
RiboMed developed proprietary epigenetic and genetic biomarker tests for personalized medicine. Their products included multi-biomarker epigenetic assays for disease screening, diagnosis, prognosis, theranostics, and post-treatment monitoring—especially in oncology. They notably launched improved prognostic multi-biomarker epigenetic tests for brain cancer to predict drug response based on MGMT methylation status. The company also worked on diagnostics for endometriosis and ovarian cancer. As of the most recent information available in business directories and industry profiles from Craft.co and others as of early/mid–2020s, the company has ceased operations ("Status Closed"). There are no recent reports of active product launches or ongoing programs after that period.
No current clinical results or pipeline updates are available due to closure.
- Therapeutic areas
- OtherOncologyWomen's Health
- Modalities
- Epigenetic biomarker testsgenetic biomarker tests (diagnostics)
- Industry
- Molecular Diagnostics
02
Partnerships
No major pharmaceutical partnerships specifically named in public sources. The company was listed among notable players in the companion diagnostics market but without explicit partnership details.
Beyond the preview
Go deeper on RiboMed Biotechnologies, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RiboMed Biotechnologies, Inc..